119th Congress · introduced in the House · Apr 16, 2026
Breast Cancer Research Stamp Reauthorization Act of 2026
Official title from Congress.gov
Latest action (Apr 16, 2026): Referred to the Committee on Oversight and Government Reform, and in addition to the Committees on Energy and Commerce, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
View on Congress.govPolicy area: Health
No official summary has been published for this bill.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Referred to the Committee on Oversight and Government Reform, and in addition to the Committees on Energy and Commerce, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Oversight and Government Reform, and in addition to the Committees on Energy and Commerce, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Oversight and Government Reform, and in addition to the Committees on Energy and Commerce, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Introduced in House
Actions from Congress.gov, newest first.
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 23, 2026.
18 citations.
THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN · lobbying firm or registrant: THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 23, 2026 · issue area: Health Issues
$70,000
Spent on own lobbying
….2339 - The EARLY Act Reauthorization of 2025; a bill to reauthorize the Young Womens Breast Health Education and Awareness Requires Learning Young Act of 2009 H.R.8358/S.4318 - Breast Cancer Research Stamp Reauthorization Act; efforts to introduce a bill to amend title 39, United States Code, to extend the authority of the Un…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN · lobbying firm or registrant: THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 23, 2026 · issue area: Postal
$70,000
Spent on own lobbying
H.R.8358/S.4318 - Breast Cancer Research Stamp Reauthorization Act; efforts to introduce a bill to amend title 39, United States Code, to extend the authority of the Un…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · lobbying firm or registrant: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Health Issues
$1,790,000
Spent on own lobbying
…units to expand patient access to essential screening services in rural and underserved communities. Breast Cancer Research Stamp Reauthorization Act of 2026, H.R.8358, S.4318. This bill would allow the U.S. Postal Service to extend its authority to issue the Breast Cancer Research semipostal stamp for 10 more years to raise…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SUSAN G. KOMEN · lobbying firm or registrant: ARTEMIS POLICY GROUP LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Health Issues
$40,000
Paid to lobbying firm
…d to the impact of tariffs on the availability of silicone prosthetics National Breast Cancer Awareness Month Breast Cancer Research Stamp Reauthorization Act (H.R. 8358) Breast Cancer Stamp Reauthorization Act (S.4318) Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee; Notice of Meeting; Establish…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN COLLEGE OF SURGEONS PROFESSIONAL ASSOCIATION · lobbying firm or registrant: AMERICAN COLLEGE OF SURGEONS PROFESSIONAL ASSOCIATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 15, 2026 · issue area: Medicare/Medicaid
$40,000
Spent on own lobbying
…Act S. 4582/H.R. 7198 - Reintroduction of Ensuring Access to General Surgery Act H.R. 7520 - Efficiency Adjustment Delay Act H.R. 5509/S. 2903 - Safe Step Act H.R. 8358/S. 4318 - Breast Cancer Stamp Reauthorization Act H.R. 9693/S. 5672 - Patients First Act of 2026 H.R. 4583/S. 1552 - Living Donor Protection Act of 2026 H.R. 8…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN COLLEGE OF SURGEONS PROFESSIONAL ASSOCIATION · lobbying firm or registrant: AMERICAN COLLEGE OF SURGEONS PROFESSIONAL ASSOCIATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 15, 2026 · issue area: Health Issues
$40,000
Spent on own lobbying
…Act S. 4582/H.R. 7198 - Reintroduction of Ensuring Access to General Surgery Act H.R. 7520 - Efficiency Adjustment Delay Act H.R. 5509/S. 2903 - Safe Step Act H.R. 8358/S. 4318 - Breast Cancer Stamp Reauthorization Act H.R. 9693/S. 5672 - Patients First Act of 2026 H.R. 4583/S. 1552 - Living Donor Protection Act of 2026 H.R. 8…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN COLLEGE OF SURGEONS · lobbying firm or registrant: AMERICAN COLLEGE OF SURGEONS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 15, 2026 · issue area: Medicare/Medicaid
$230,000
Spent on own lobbying
…Act S. 4582/H.R. 7198 - Reintroduction of Ensuring Access to General Surgery Act H.R. 7520 - Efficiency Adjustment Delay Act H.R. 5509/S. 2903 - Safe Step Act H.R. 8358/S. 4318 - Breast Cancer Stamp Reauthorization Act H.R. 9693/S. 5672 - Patients First Act of 2026 H.R. 4583/S. 1552 - Living Donor Protection Act of 2026 H.R. 8…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN COLLEGE OF SURGEONS · lobbying firm or registrant: AMERICAN COLLEGE OF SURGEONS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 15, 2026 · issue area: Health Issues
$230,000
Spent on own lobbying
…Act S. 4582/H.R. 7198 - Reintroduction of Ensuring Access to General Surgery Act H.R. 7520 - Efficiency Adjustment Delay Act H.R. 5509/S. 2903 - Safe Step Act H.R. 8358/S. 4318 - Breast Cancer Stamp Reauthorization Act H.R. 9693/S. 5672 - Patients First Act of 2026 H.R. 4583/S. 1552 - Living Donor Protection Act of 2026 H.R. 8…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN · lobbying firm or registrant: THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 21, 2026 · issue area: Health Issues
$130,000
Spent on own lobbying
…2339 - The EARLY Act Reauthorization of 2025; a bill to reauthorize the Young Womens Breast Health Education and Awareness Requires Learning Young Act of 2009. H.R.8358/S.4318 - Breast Cancer Research Stamp Reauthorization Act; efforts to introduce a bill to amend title 39, United States Code, to extend the authority of the Un…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN · lobbying firm or registrant: THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 21, 2026 · issue area: Postal
$130,000
Spent on own lobbying
H.R.8358/S.4318 - Breast Cancer Research Stamp Reauthorization Act; efforts to introduce a bill to amend title 39, United States Code, to extend the authority of the Un…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS · lobbying firm or registrant: AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Health Issues
$96,000
Spent on own lobbying
…rder Awareness and Research Act; H.R. 9441, SAFE Training for OBGYNs Act; H.R. 9061, PREEMPT Act; H.Res. 1282, a resolution recognizing ACOGs 75th anniversary; H.R. 8358, Breast Cancer Research Stamp Reauthorization Act; S. Res. 710, a resolution recognizing Maternal Mental Health Day; H.R. 9090/S. 4503, Advancing Menopause Car…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · lobbying firm or registrant: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Health Issues
$1,240,000
Spent on own lobbying
…units to expand patient access to essential screening services in rural and underserved communities. Breast Cancer Research Stamp Reauthorization Act of 2026, H.R.8358, S.4318. This bill would allow the U.S. Postal Service to extend its authority to issue the Breast Cancer Research semipostal stamp for 10 more years to raise…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN COLLEGE OF SURGEONS PROFESSIONAL ASSOCIATION · lobbying firm or registrant: AMERICAN COLLEGE OF SURGEONS PROFESSIONAL ASSOCIATION
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 16, 2026 · issue area: Medicare/Medicaid
$30,000
Spent on own lobbying
…Act S. 4582/H.R. 7198 - Reintroduction of Ensuring Access to General Surgery Act H.R. 7520 - Efficiency Adjustment Delay Act H.R. 5509/S. 2903 - Safe Step Act H.R. 8358/S. 4318 - Breast Cancer Stamp Reauthorization Act Merit based Incentive Payment System (MIPS) Reform Value-Based Care (VBC) healthcare model CMS TEAM Model Nat…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN COLLEGE OF SURGEONS PROFESSIONAL ASSOCIATION · lobbying firm or registrant: AMERICAN COLLEGE OF SURGEONS PROFESSIONAL ASSOCIATION
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 16, 2026 · issue area: Health Issues
$30,000
Spent on own lobbying
…Act S. 4582/H.R. 7198 - Reintroduction of Ensuring Access to General Surgery Act H.R. 7520 - Efficiency Adjustment Delay Act H.R. 5509/S. 2903 - Safe Step Act H.R. 8358/S. 4318 - Breast Cancer Stamp Reauthorization Act Merit based Incentive Payment System (MIPS) Reform Value-Based Care (VBC) healthcare model CMS TEAM Model Nat…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN COLLEGE OF SURGEONS · lobbying firm or registrant: AMERICAN COLLEGE OF SURGEONS
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 16, 2026 · issue area: Medicare/Medicaid
$240,000
Spent on own lobbying
…Act S. 4582/H.R. 7198 - Reintroduction of Ensuring Access to General Surgery Act H.R. 7520 - Efficiency Adjustment Delay Act H.R. 5509/S. 2903 - Safe Step Act H.R. 8358/S. 4318 - Breast Cancer Stamp Reauthorization Act Merit based Incentive Payment System (MIPS) Reform Value-Based Care (VBC) healthcare model CMS TEAM Model Nat…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN COLLEGE OF SURGEONS · lobbying firm or registrant: AMERICAN COLLEGE OF SURGEONS
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 16, 2026 · issue area: Health Issues
$240,000
Spent on own lobbying
…Act S. 4582/H.R. 7198 - Reintroduction of Ensuring Access to General Surgery Act H.R. 7520 - Efficiency Adjustment Delay Act H.R. 5509/S. 2903 - Safe Step Act H.R. 8358/S. 4318 - Breast Cancer Stamp Reauthorization Act Merit based Incentive Payment System (MIPS) Reform Value-Based Care (VBC) healthcare model CMS TEAM Model Nat…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN · lobbying firm or registrant: THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Postal
$80,000
Spent on own lobbying
H.R.8358/S.4318 - Breast Cancer Research Stamp Reauthorization Act; efforts to introduce a bill to amend title 39, United States Code, to extend the authority of the Un…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN · lobbying firm or registrant: THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Health Issues
$80,000
Spent on own lobbying
…2339 - The EARLY Act Reauthorization of 2025; a bill To reauthorize the Young Womens Breast Health Education and Awareness Requires Learning Young Act of 2009. H.R.8358/S.4318 - Breast Cancer Research Stamp Reauthorization Act; efforts to introduce a bill to amend title 39, United States Code, to extend the authority of the Un…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing